About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CGEN - Compugen Ltd.| Previous Close | $15.51 | Open | $15.54 |
| Volume | 1.7M | Market Cap | 1.285B |
| Yield | Last Dividend |
| Compugen Starts Dosing In Early-Stage Co... | 09/09/20 |
| Israel-based cancer immunotherapy firm Compugen announced that the first patient has been dosed in the Phase 1/2 study of COM701 with Bristol Myers ??... | |
| We spoke to 3 financial experts, who bro... | 06/11/20 |
| With the stock market climbing off multiyear lows, investors are seeking opportunities in a market that's confounded even the top Wall Street strategi... | |
| Is the Options Market Predicting a Spike... | 05/18/20 |
| Investors need to pay close attention to Compugen (CGEN) stock based on the movements in the options market lately. | |
| Compugen (CGEN) is a Great Momentum Stoc... | 04/30/20 |
| Does Compugen (CGEN) have what it takes to be a top stock pick for momentum investors? Let's find out. | |
| Thinking about buying stock in Bed Bath ... | 04/16/20 |
| NEW YORK, April 16, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBBY, CGEN, CODX, GE, and TRIP. To see how InvestorsO... | |
| Compugen Projected to Rise Over 100% in ... | 03/24/20 |
| No summary available. | |
| Compugen prices $75M stock offering | 03/12/20 |
| Compugen (NASDAQ:CGEN) has priced its public offering of ~8.3M ordinary shares at $9.00 per share, for expected gross proceeds of ~$75M. Underwriters'... | |
| A CIO overseeing $230 million explains h... | 01/17/20 |
| Gerry Frigon, founder and chief investment officer at Taylor Frigon Capital Management, has found a way to play in the high-risk, high-reward biotechn... | |
| Compugen Announces Appointment of Dr. Ol... | 01/08/20 |
| HOLON, Israel, Jan. 8, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive tar... | |
| FoxWise Technologies Inc. and Compugen I... | 11/21/19 |
| OTTAWA, Ontario & RICHMOND HILL, Ontario--(BUSINESS WIRE)--Compugen Inc. acquires a minority interest in Indigenous IT company FoxWise. | |
| Compugen (NASDAQ:CGEN) Issues Quarterly ... | 11/12/19 |
| Compugen (NASDAQ:CGEN) issued its earnings results on Monday. The biotechnology company reported ($0.10) EPS for the quarter, topping the consensus es... | |
| Compugen (CGEN) Upgraded to Buy: Here's ... | 05/23/19 |
| Compugen (CGEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | |
| Compugen Ltd. (CGEN) Q1 2019 Earnings Ca... | 05/20/19 |
| CGEN earnings call for the period ending March 31, 2019. | |
| Compugen Ltd. (CGEN) CEO Anat Cohen-Daya... | 05/20/19 |
| No summary available. | |
| Compugen begins patient dosing in early-... | 05/20/19 |
| No summary available. | |
| Compugen beats by $0.03 | 05/20/19 |
| No summary available. | |
| What Makes Compugen (CGEN) a New Strong ... | 04/18/19 |
| Compugen (CGEN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might driv... | |
| Compugen nabs two new patents in U.S. fo... | 03/12/19 |
| No summary available. | |
| Compugen Ltd. (CGEN) CEO Anat Cohen-Daya... | 02/26/19 |
| No summary available. | |
| Compugen down 8% on Q4 results | 02/26/19 |
| No summary available. | |
| Compugen beats by $0.04 | 02/26/19 |
| No summary available. | |
| ARNC, RNN, EDIT and SDLP among notable m... | 01/22/19 |
| No summary available. | |
| ARNC, RNN, EDIT and SDLP among notable m... | 01/22/19 |
| No summary available. | |
| Spectrum Of Momentum Stocks Dominating T... | 01/11/19 |
| No summary available. | |
| Spectrum Of Momentum Stocks Dominating T... | 01/11/19 |
| No summary available. | |
| Strong Buy rating | 08/19/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $15.00 to $19.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Options Eagle | George | 79.00 % | Follow |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
